Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma

The fibroblast growth factor (FGF) signaling cascade is one of the key signaling pathways in hepatocellular carcinoma (HCC). FGF has been shown to augment vascular endothelial growth factor (VEGF)-mediated HCC development and angiogenesis, as well as to potentially lead to resistance to VEGF/VEGF re...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Thi Bich Uyen, Vu, Thanh Chung, Ho, Rebecca Zhi Wen, Prawira, Aldo, Wang, Lingzhi, Goh, Boon Cher, Huynh, Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764786/
https://www.ncbi.nlm.nih.gov/pubmed/33321903
http://dx.doi.org/10.3390/ijms21249405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764786/
https://www.ncbi.nlm.nih.gov/pubmed/33321903
http://dx.doi.org/10.3390/ijms21249405

Ejemplares similares